Giulio Francia The University of Texas El Paso, TX USA Biography
Biography of Giulio Francia
Dr. Francia began his career by undertaking a PhD with Dr. Ian Hart at the Imperial Cancer Research Fund in London, UK, which has since evolved into Cancer UK. After his PhD, he trained with Dr. Robert Kerbel in Toronto, Canada, on aspects of metastasis, therapies for metastatic disease, and tumor resistance to therapy. He is now Assistant Professor at The University of Texas at El Paso, where he is attempting to set up a research program that is internationally recognized for pioneering new cancer therapeutic ideas, and for generating in vivo models to help translate laboratory findings into the clinic - by developing new metastatic tumor models, and by refining those he has already established.
Urban Emmenegger Sunnybrook Health Sciences Centre Toronto, ON Canada Biography
Biography of Urban Emmenegger
Dr. Urban Emmenegger obtained his medical degree from the University of Bern/Switzerland, followed by training in Internal Medicine and Medical Oncology, and research training in tumor biology, with special emphasis on tumor angiogenesis and metronomic chemotherapy. Currently, Dr. Emmenegger is appointed as Staff Medical Oncologist and Scientist at Odette Cancer Centre & Sunnybrook Research Institute, and is Assistant Professor in the Department of Medicine, all at the University of Toronto/Canada. Dr. Emmenegger is specialized in the treatment of advanced prostate cancer, a disease which is also at the center of his research interests. He is particularly interested in improving the use of metronomic chemotherapy for prostate cancer, in understanding therapeutic resistance, and identifying predictive biomarkers.
D. Fan Fourth Military Medical University Xi'an China Biography
Biography of D. Fan
Professor Daiming Fan is the member and vice president of Chinese Academy of Engineering, foreign associate of the USA National Academy of Medicine, past president of Fourth Military Medical University, past president of Chinese Society of Gastroenterology, director of Xijing Hospital of Digestive Diseases, and director of State Key Laboratory of Cancer Biology. He is now the vice president of Chinese Anti-Cancer Association, and vice president of Asian Pacific Association of Gastroenterology. As the congress president, he successfully organized the GASTRO2013 (WCOG/APDW) in Shanghai. He was the first awardee of the Prize “French National Academy of Medicine-Servier”.
K.X. Sun Harbin Medical University Harbin China Biography
Biography of K.X. Sun
Dr Xueying Sun obtained MD and PhD from Shandong University in 1994. He is currently holding a professorial position at the Department of Surgery, the Affiliated Hospital of Harbin Medical University, and a position of Honorary Senior Research Fellow at Department of Molecular Medicine & Pathology, FMHS, University of Auckland. His present research and professional specialities include tumor hypoxia, cancer molecular targeted therapy, cellular signalling and non-coding RNAs. He was a winner of World Health Organization Fellowship (1999-2000) and Wellcome Trust Leave Fellowship (2001-2005). He has published over 200 research articles in peer-viewed journals including 120 articles in Science Citation Index journals. He is also a member of Editorial board of five academic journals, and a member of the review panels for National Natural Scientific Foundation, Ministry of Science and Technology and Ministry of Education of China.
Dr. Bocci is a professor of Pharmacology at the University of Pisa. He obtained the degree of Medicine (1995), the degree of Clinical Pharmacology (1999) and a PhD in Pharmacology (2003) from the University of Pisa. Dr. Bocci was post-doctoral fellow for 3 years at the University of Toronto. Dr. Bocci is PI of projects granted by international associations, foundations and pharmaceutical companies. He is member of ASCO and AACR. He is author of more than 130 scientific papers published on international journals, 11 chapters on books, and 5 patents. He is regional editor of Clinical Cancer Drugs from the foundation of the journal.
N.S. Yee Penn State Hershey Cancer Institute Hershey, PA USA Biography
Biography of N.S. Yee
Dr. Yee obtained a medical doctorate (M.D.) and a doctorate (Ph.D.) in Molecular Biology from Cornell University. Currently, Dr. Yee is an Assistant Professor of Medicine in Hematology and Oncology in the Pennsylvania State University College of Medicine. He is also a medical oncologist in the PennState Cancer Institute, and an attending and consultant physician in the PennState Milton S. Hershey Medical Center. He has published extensively in basic, translational, and clinical sciences, including original research articles, review articles, book chapters, and clinical case reports. Dr. Yee is currently the Regional Editor of this journal (Clinical Cancer Drugs), published by Bentham Science Publishers.
Editorial Board Members
J. Brabek Charles University Prague Czech Republic Biography
Biography of J. Brabek
Jan Brábek is an Associate Professor at Charles University and BIOCEV and a principal investigator of laboratory of Cancer Cell Invasion. His areas of expertise are individual cancer cell invasiveness (molecular and cellular mechanisms of mesenchymal and amoeboid invasiveness, invasive structures – podosomes, invadopodia) and integrin-mediated Src signalling (signalling through FAK/Src and p130CAS, regulation of Src and its signalling), phosphoproteomics of Src-transformed cells. He is a member of the Invadosome Consortium, in 2006 he received an Award of the League Against Cancer.
J.CS. Chim Queen Mary Hospital Hong Kong China Biography
Biography of J.CS. Chim
Prof James CS Chim is a clinician scientist interested in the multiple myeloma. He is a Member of the International Myeloma Working Group, Executive Council Member of the Asian Myeloma Network, Founding member of the International Academy of Clinical Hematology (IACH) & Founding Chairman of the Hong Kong Society of Myeloma. He has published in excess of 240 articles in peer-reviewed journals including Blood, Leukemia and Journal of Clinical Oncology.
S. Cos Corral University of Cantabria Cantabria Spain Biography
Biography of S. Cos Corral
Samuel Cos, M.D. in 1983 and Ph.D. in 1986, is Full Professor and Head in the Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, Santander, Spain. For over 30 years, Dr. Cos’s research has focused on the oncostatic actions of melatonin, particularly in breast cancer. He has published over 100 journal articles, book chapters and reviews on this topic. His research has been supported by Spanish and European funding agencies. He currently serves on the editorial boards of the Clinical Cancer Drugs, Journal of Tumor and Dataset Papers in Medicine: Oncology.
A. Di Paolo University of Pisa Pisa Italy Biography
Biography of A. Di Paolo
Antonello Di Paolo received his MD (1992) and degree in Pharmacology (2000) from the University of Pisa, Italy, while he gained his PhD (1997) at the Superior School of University Studies in Pisa. Currently, Antonello Di Paolo is associate professor of Pharmacology at the University of Pisa and physician at the Unit of Clinical Pharmacology and Pharmacogenetics, Civil Hospital, Pisa. His main research is focused on pharmacokinetics and pharmacogenetics of anticancer agents, with special interest in fluoropirimidines in colorectal cancers, small tyrosine kinase inibitors and immunomodulating agents in hematological malignancies. He is authors of more than 100 articles published on indexed international journals.
Q. P. Dou Wayne State University Detroit, MI USA Biography
Biography of Q. P. Dou
Dr. Q. Ping Dou is Professor of Oncology, Pharmacology and Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. He obtained his B.S. degree in chemistry from Shandong University in 1981, Ph.D. degree in chemistry from Rutgers University in 1988, and postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School from 1988 to 1993. Dr. Dou has extensive experience in the fields of molecular targeting, drug discovery, chemoprevention, natural products, proteasome inhibitors, cell cycle and apoptosis, and has published ~222 peer-reviewed research and review articles, many of those in journals of the highest quality.
A.W. Griffioen VU University Medical Center Amsterdam The Netherlands Biography
Biography of A.W. Griffioen
Dr. Griffioen obtained his PhD in immunology and medicine from the Utrecht University, The Netherlands. He is Being trained and formally registered as an immunologist, dr Griffioen’s research interest is in vascular biology and angiogenesis. He is currently professor of experimental oncology and angiogenesis and is heading the Angiogenesis Laboratory at the VU University Medical Center in Amsterdam. Dr. Griffioen has published over 220 scientific publications, is inventor on 20 patents and is the founding Editor-in-Chief of the journal Angiogenesis (1997).
J. Ho The University of Hong Kong Hong Kong China Biography
Biography of J. Ho
Dr. James Ho is an Associate Professor and Honorary Consultant at the Department of Medicine, Queen Mary Hospital, The University of Hong Kong (HKU). He received his medical degree (M.B.,B.S.) in 1993 and M.D. in 2007 from HKU, with training in internal medicine and respiratory medicine. He is FCCP and FRCP (Edin, Lond and Glasg). Dr. Ho has an established track record in lung cancer research, and the areas of focus over the years include preclinical models, the role of antioxidants, epidemiology, diagnostics, and clinical trials. He has published more than 90 papers in peer-reviewed journals.
K. Kalani University of Kansas Lawrence, KS USA Biography
Biography of K. Kalani
I received my PhD in Chemistry from CSIR-CIMAP. I worked on Indian medicinal plants with top notch safety standards, Structure Activity Relationship (SAR) and in-silico computational studies. The formulations were validated against cancer, malaria, filaria and tubercular assays. I started working as Post-doctoral researcher in Department of Pharmacology and toxicology, University of Kansas. I am currently involved in organic synthesis, lead identification, and characterization for their bio-availability against Alzheimer’s disease and diabetes. In silico virtual screening, pharmacophore query elucidation, QSAR, docking, ADME/T, mutation exercise are part of my research. Animal handling and their database has been credited to my ongoing work.
M. Koutsilieris University of Athens Athens Greece Biography
Biography of M. Koutsilieris
Prof. Michael Koutsilieriswas born in Piraeus, Greece (1954), and he graduated the Medical School of National & Kapodistrian University of Athens (1980). Then he was trained in "Endocrinology" at the Division of Endocrinology, Department of Medicine, Royal Victoria Hospital, McGill University, Quebec, Canada (1982-1987). There he obtained also his Ph.D degree at the Department of Experimental Medicine, McGill University (1987). He was appointed as a Research Associate, Department of Biochemistry & Molecular Biology, Faculty of Medicine, Sherbrooke University, Quebec, Canada and as an Assistant (1988), Associate and full Professor (1997) at the Faculty of Medicine, Laval University, Quebec, Canada.
W. Li The Second Military Medical University Shanghai China Biography
Biography of W. Li
Dr. Wei Li is a Professor from the Second Military Medical University. He obtained his PhD from the Chinese University of Hong Kong, and postdoctoral training in Hong Kong Polytechnic University, and then took the research assistant professor position in Tokyo Women’s Medical University from 2007. Since 2010, he works in the Second Military Medical University by the special talent program to set up a new nanomedical lab. His current research mainly focus on nano physical pharmaceutics and anti-tumor nanoimmunotherapy.
P. Limonta University of Milan Milan Italy Biography
Biography of P. Limonta
Dr. Limonta obtained a Degree in Pharmaceutical Chemistry and Technology and a Degree in Pharmacy from the University of Milano, Italy. She also holds a Postdoctoral Degree in Pharmacology and a Postdoctoral Degree in Experimental Endocrinology from the University of Milano, Italy. She has been Postdoctoral fellow in Biology of Reproduction at the Population Council, Center for Biomedical Research, New York (1983-1984).
Currently, Dr. Limonta is Associate Professor of Applied Biology, at the University of Milano. She has published 90 scientific peer-reviewed publications, most of them in the field of molecular oncology.
She is currently Editorial Advisory board Member of the journal 'Clinical Cancer Drugs'.
S.E. Lipshultz Wayne State University Detroit, MI 48201 USA
P. Lockman West Virginia University Health Sciences Center Morgantown, WV USA Biography
Biography of P. Lockman
Dr. Paul Lockman is a Professor and the Douglas Glover Endowed Chair for Pharmaceutical Sciences at West Virginia University School of Pharmacy, as well as the Associate Director for Translational Research at the Mary Babb Randolph Cancer Center in the West Virginia Cancer Institute. Dr. Lockman specializes in the mathematical modelling of drug entry into brain. His work has led to an understanding of how the specialized vasculature of the brain limits chemotherapy from reaching brain metastases of breast cancer at effective concentrations.
A.S. Mellick The University of New South Wales Sydney Australia Biography
Biography of A.S. Mellick
Dr. Albert Mellick is an Associate Professor in Medical Oncology, University of New South Wales (UNSW), and member of the Ingham Institute for Applied Medical Research. Dr. Mellick runs an Australian Research Council and National Medical Research Council funded lab, and he has authored many research publications focused on the understanding and treatment of cancer malignancy. Prior to his current appointment he has served as foundation Chair Pharmacology, Deakin University; foundation Griffith Medical Research College Fellow, and Research Fellow, Cold Spring Harbor Laboratories; where he developed methods in retro-viral delivery of inhibitory RNAs and published seminal papers on endothelial progenitors.
H. Nagai Toho University Omori Medical Center Tokyo Japan
Gianfranco Natale is associate professor of Human Anatomy at the University of Pisa. He obtained the degree of Medicine (1990) and the degree of Clinical Pharmacology (2004) from the University of Pisa. He participated in the organization of scientific congresses and exhibitions. He is author of more than 80 scientific papers published on international journals, 20 chapters on books, and 1 book. He is director of the Museum of Human Anatomy “Filippo Civinini” of the University of Pisa and he is interested in the history of medicine.
P. Nowak-Sliwinska University Hospital Lausanne (CHUV) Lausanne Switzerland Biography
Biography of P. Nowak-Sliwinska
Prof. Patrycja Nowak-Sliwinska joined the School of Pharmaceutical Sciences of the University of Geneva in June 2016. She is a head of Molecular Pharmacology Group and with her team she currently works, in a close collaboration engineers and with clinical partners, on personalized optimization of multi-drug combinations for cancer treatment.
B.L. Parsons US Food and Drug Administration Jefferson, AR USA Biography
Biography of B.L. Parsons
Barbara Parsons is a Principal Investigator, Research Microbiologist within the Division of Genetic and Molecular Toxicology at the US Food and Drug Administration’s National Center for Toxicological Research. At NCTR, Dr. Parsons developed a highly-sensitive, allele-specific competitive blocker-PCR method to quantify specific hotspot cancer-driver gene mutations at low frequency. Her group at NCTR has produced a large body of work validating ACB-PCR measurement of hotspot cancer driver mutations in PIK3CA, and EGFR, as biomarkers for assessing the carcinogenic potential of chemical exposures in rodents, biomarkers of cancer susceptibility in human tissues, and as biomarkers of therapeutic resistance in human tumors.
Y. Peng The University of Texas Southwestern Medical Center Dallas, TX USA Biography
Biography of Y. Peng
Yan Peng, MD, PhD is a Professor of Pathology at UT-Southwestern Medical Center. She serves as Pathology Liaison at Cancer Committee of the Simmons Cancer Center and University Hospitals. She is President of North Texas Society of Pathologists and President of International Association of Chinese Pathologists. She served as Medical Directors for CLIA certified Immunohistochemistry, Image Analysis and FISH Labs for about 10 years. Her research is focused on diagnostic, prognostic, and predictive biomarkers in breast cancer and gynecologic cancer. She has authored over 70 peer-reviewed articles and several book chapters. She is an Editor-Board Member in multiple scientific journals.
T. Pitts University of Colorado School of Medicine Aurora, CO USA Biography
Biography of T. Pitts
Todd Pitts is an Assistant Professor at the University of Colorado Denver Anschutz Medical Campus. He earned his PhD in Medical and Surgical Oncology and Clinical Immunology at
the Second University of Naples. Todd Pitts’ research is focused on pre-clinical studies of novel, targeted therapies for the treatment of advanced colorectal and pancreatic cancer, utilizing both in vitro cell culture models and in vivo mouse model systems. These studies serve as a rational basis for therapeutic treatment choices for patients with advanced GI cancers in the Cancer Center’s Phase I Clinical Trials Program.
A. Salimi Ardabil University of Medical Sciences Ardabil Iran Biography
Biography of A. Salimi
Ahmad Salimi is an assistant professor of toxicology in the Department of Pharmacology and Toxicology at the Ardabil University of Medical Sciences. He studied Toxicology in Ahvaz (Ahvaz Jundishapur University of Medical Sciences) and did his PhD in Tehran (Shahid Beheshti University of Medical Sciences). His research focuses on the selective toxicity new drugs on cancer cell, the interface between chemical agents and immune system, mechanistic toxicology using isolated cells and mitochondria and also cell culture. A special interest is the using of mitochondria for therapy various diseases. He (co-)authored over 60 papers and 6 book chapters
C. Saturnino University of Basilicata Potenza Italy Biography
Biography of C. Saturnino
Professor in Medicinal Chemistry University of Basilicata, Department of Science.1989 University Louis Pasteur in Strasbourg (F) (DEA) - Pharmacologie et Pharmacochimie, option : Pharmacochimie. Supervisors prof.C.G.Wermuth and J.J.Bourguignon. 1991-1993: Fellow of the Pharmaceutical Industry -Servier in Paris and later the University of Caen (F). Co-autor: 114 (publications, 6 Patent, ecc.). Research Interest: Carbazoles, Organometallic compounds, Pyrazoles, Suzuki reaction, Design, Synthesis and biological studies and understanding of the mechanisms of action of new therapeutic molecules for: cancer, neurodegenerative diseases, antimicrobial agents.
E. Segal Paris Descartes University Saints-Peres, Paris France Biography
Biography of E. Segal
Received her MD from Necker Hospital (Paris Descartes University, France) and her PhD in Molecular and cellular Biology from Pierre and Marie Curie University (Paris, France). After working in Molecular and Biological Pharmacology in Gustave-Roussy Institute (Villejuif, France), she obtained a position as a research scientist at CNRS. She joined Saint-Louis Hospital (Paris, France) in 1998 where she became a team leader as a Research Director working on the pharmacological and physiological regulation of the telomerase expression and activity in an INSERM Unit. She joined Paris Descartes University in 2010 where she became the head of INSERM UMR-S 1007 named "Cellular Homeostasis and Cancer".
H. Tang Tianjin Medical University Tianjin China Biography
Biography of H. Tang
Dr. Tang obtained his Medical Doctor Degree and Ph.D. in Pathogen Biology from Tianjin Medical University, and gained postdoctoral training in Harvard University and HHMI. He was a faculty member in Harvard Medical School and Fudan University. Currently Dr. Tang is a Professor and Chair of Tianjin Life Science Research Center and Department of Pathogen Biology, Tianjin Medical University. Dr. Tang has focused on the regulation of non-coding RNA on tumorigenesis and viral proliferation. He has published more than 100 research articles and served as an editor of more than 10 journals.
Y. Tutar Cumhuriyet University Sivas Turkey Biography
Biography of Y. Tutar
Dr. Yusuf TUTAR currently continues his research in University of Health Sciences, Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Division of Biochemistry- Mektebi Tıbbiye-i Sahane Turkey. He is also the head of Molecular Medicine Program. He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of drug design, protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, epigenetics, metabolites, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.
P.J. Vlachostergios New York-Presbyterian Hospital New York, NY USA Biography
Biography of P.J. Vlachostergios
Dr. P.J. Vlachostergioshas a degree in Medicine and a Ph.D. in cancer cell biology. He completed his residency at New York University School of Medicine, NYU Langone Hospital-Brooklyn and continued his training at the Division of Hematology/Oncology, Weill Medical College of Cornell University, New York. His studies have focused on: a) cachexia and immune responses in lung cancer b) proteasome inhibition in glioma c) neuroendocrine differentiation of prostate cancer d) DNA repair gene mutations in urothelial cancer e) chemotherapy and immunotherapy resistance in urothelial carcinoma. He is author, reviewer and editorial board member of several international peer-reviewed journals.
F. Yang Guangxi normal university Guangxi China Biography
Biography of F. Yang
Dr. Feng Yang was associate researcher of Brookhaven national lab in USA after graduated from Chinese academy of sciences. He is primary investigator of State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources. He has been interested in design anticancer metal drug based on the protein structure, protein-based drug delivery systems, and multi-drug combination therapy of cancer.
M.C. Yergeri Dr. Bhanuben Nanavati College of Pharmacy Mumbai India
J.-H. Zhong Affiliated Tumor Hospital of Guangxi Medical University Nanning China
Associate Editorial Board Members
J. Gasparotto Federal University of Rio Grande do Sul (UFRGS) Porto Alegre Brazil Biography
Biography of J. Gasparotto
Dr. J. Gasparotto graduated in Physical Education from Universidade Luterana do Brasil-ULBRA. His Post-graduation was in Exercise Physiology and Training Prescription from Gama Filho University of Rio de Janeiro. Later, he did Master and PhD in Biological Sciences - Biochemistry by Federal University of Rio Grande do Sul-UFRGS. Currently, he is linked with the National Postdoctoral Program of CAPES and collaborator of the Department of Biochemistry of UFRGS. He has experience with several experimental models, including rodents, cell culture and clinical studies.
D. Giles Acharya & BM Reddy College of Pharmacy Bengaluru India
R. Mishra Manipal University Jaipur Jaipur India Biography
Biography of R. Mishra
Dr. Rajeev Mishra is Assistant Professor in the Department of Biosciences at Manipal University Jaipur, India. Dr Mishra, prior to Joining Manipal University Jaipur, was Project Scientist at Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, California, USA. After finishing Ph.D. in 2007, he joined Department of Cancer Genetics, Nihon University School of Medicine, Tokyo, Japan as the post-doctoral fellow. Dr Mishra has published several research papers in almost all top cancer journals. He has more than 16 years of experience in cancer drug discovery research and therapeutic resistance.
L. Motadi North-West University Mmabatho South Africa Biography
Biography of L. Motadi
Dr. Motadi is an academic cancer researcher with over 17 years postdoctoral experience encompassing undergraduate and postgraduate teaching and supervision with extensive research experience. Sustained international scientific standing, evidenced by sustained publications in high impact international journals. Currently he is National Research Foundation (NRF) rated scientist. His research background are in a highly specialized area of molecular oncology, new drug target identification and apoptosis. The research interest mainly using new or old small molecule targets to restore the cellular molecular machinery in cancer cell.
A. Rochani Thomas Jefferson University Philadelphia, PA USA Biography
Biography of A. Rochani
Dr. Rochani is presently working as a postdoctoral research fellow at Department of Pharmaceutical Science, Thomas Jefferson University, Philadelphia, USA. He was awarded Japanese Govt. (MEXT) fellowship for pursuing Ph.D. in Bio Nano Science from Toyo University, Japan. He has published many research papers and given scientific presentations at various international conferences in the field of drug development and delivery using nanotechnology and mass spectrometry. He is a reviewer for many peer-reviewed high impact scientific journals. He has significant expertise in formulation and bioanalytical chemistries for drug development. His work focuses on developing polymeric controlled drug delivery systems for pathologies like cancer.
M. Rogalinska University of Lodz Lodz Poland Biography
Biography of M. Rogalinska
Małgorzata Rogalinska completed Her PhD degree at the Department of cytobiochemistry, Faculty of biology and Environmental Protection, University of Lodz, Poland. Since year 2011 till 2013 she was a principal investigator of grant entitled: “Personalized therapy for chronic lymphocytic leukemia”. Since April 2017 she became Associate Professor at the department of Cytobiochemistry, University of Lodz, Poland. She has published more than 20 papers in reputed journals or presented more than 50 posters on domestic or international conferences. She was also serving as reviewer in many international journals (eg. Spandidos Publications, Bentham Science or Elsevier).
M. Sedic University of Rijeka Rijeka Croatia Biography
Biography of M. Sedic
Dr. Mirela Sedic is an Associate Professor at the University of Rijeka Department of Biotechnology in Croatia. She is author/co-author of more than 30 scientific publications in peer-reviewed journals including high-impact journals such as Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, and Cancer Treatment Reviews. She is also co-author of book chapters in Drug Discovery, Personalized Medicine: A New Medical and Social Challenge (Springer International Publishing, 2016), and has one international patent (WO/2010/052510). Her work has been cited 755 times (h-index 14; i10-index 18). Dr. Sedic has also reviewed several international scientific journals in the past.
E. Yiannakopoulou University of West Attica Athens Greece Biography
Biography of E. Yiannakopoulou
Eugenia Yiannakopoulou: Surgeon; Endocrine Surgeon; Breast Surgeon; Pharmacologist. Current position: Faculty in the Department of Biomedical Scineces, Faculty of Health and Caring Professions, ,University of West Attica, Athens, Greece; Director of her own private medical practice. Titles: Ptychio of medicine; MSc Minimally Invasive Surgery; MSc Medical Biology; MSc Biostatistics; PhD Pharmacology; University Diploma in Breast Diseases University of Strasbourg, France; University Diploma of Laparoscopic Surgery University of Strasbourg, France. University Diploma of Endocrine Surgery University Pierre et Marrie Currie Paris, University Diploma in Targeted Biotherapeis of Inflammatory and Autoimmune Diseases, University of Montpellier, University Diploma in Inflammatory Bowel Diseases Medical School University Pierre et Marie Currie Paris.
Giulio Francia The University of Texas El Paso, TX USA